fluorodeoxyglucose f18 has been researched along with promegestone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, JA; Chan, SR; Dehdashti, F; Dence, CS; Fettig, NM; Fowler, AM; Katzenellenbogen, JA; Sharp, TL; Zhou, D | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and promegestone
Article | Year |
---|---|
Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.
Topics: Animals; Antineoplastic Agents, Hormonal; Biomarkers; Breast Neoplasms; Cell Line, Tumor; Diagnostic Imaging; Disease Models, Animal; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Humans; Ligands; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Promegestone; Receptors, Progesterone; Tomography, X-Ray Computed | 2015 |